Advertisement
Screener

Q32 Bio Inc. (QTTB) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum

2.8 / 5 stars · 68/120 Roast Me

Q32 Bio Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum

Q32 Bio Inc. (QTTB) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 112.30% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2026-08-05

  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2026-03-31 was 98.60%.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2024-09-30 was 92.90%.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2024-03-31 was 92.20%, a 32.28% increase year-over-year.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2023-06-30 was 89.80%, a 29.02% increase year-over-year.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2025 was 95.80%, a 1.81% increase from fiscal 2024.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2024 was 94.10%, a 0.11% increase from fiscal 2023.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2023 was 94.00%, a 34.09% increase from fiscal 2022.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2022 was 70.10%, a 2.23% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month as first filed
2026-06-30112.30%
10-Q · filed 2026-08-05
2026-03-3198.60%
10-Q · filed 2026-05-05
2025-12-3195.80%
10-K · filed 2026-03-10
2025-09-3095.80%
10-Q · filed 2025-11-13
2024-12-3194.10%
10-K · filed 2026-03-10
2024-09-3092.90%
10-Q · filed 2025-11-13
94.10%
10-Q · filed 2025-11-13
2024-06-3092.20%
10-Q · filed 2025-08-06
2024-03-3192.20%
10-Q · filed 2025-05-08
2023-12-3194.00%
10-K · filed 2025-03-11
69.70%
10-K · filed 2024-03-13
2023-09-3089.90%
10-Q · filed 2024-11-07
69.70%
10-Q · filed 2023-11-14
2023-06-3089.80%
10-Q · filed 2024-08-08
69.60%
10-Q · filed 2023-08-14
89.80%
10-Q · filed 2024-08-08
69.70%
10-Q · filed 2023-08-14
2023-03-3169.70%
10-Q · filed 2023-05-11
2022-12-3170.10%
10-K · filed 2024-03-13
2022-09-3070.10%
10-Q · filed 2023-11-14
2022-06-3069.60%
10-Q · filed 2023-08-14
69.60%
10-Q · filed 2023-08-14
2022-03-3169.50%
10-Q · filed 2023-05-11
2021-12-3171.70%
10-K · filed 2023-03-09
2021-09-3071.70%
10-Q · filed 2022-11-10
71.70%
10-Q · filed 2022-11-10
2021-06-3066.90%
10-Q · filed 2022-08-15
67.10%
10-Q · filed 2022-08-15
2021-03-3167.10%
10-Q · filed 2022-05-16
2020-12-3166.30%
10-K · filed 2022-03-23
2020-09-3065.20%
10-Q · filed 2021-11-15
65.40%
10-Q · filed 2021-11-15
2020-06-3065.40%
10-Q · filed 2021-08-12
65.40%
10-Q · filed 2021-08-12
2020-03-3163.50%
10-Q · filed 2021-05-06
2019-12-3164.70%
10-K · filed 2021-03-11
2019-09-3063.20%
10-Q · filed 2020-11-09
64.70%
10-Q · filed 2020-11-09
2019-06-3063.10%
10-Q · filed 2020-08-10
64.70%
10-Q · filed 2020-08-10
64.68%
10-Q · filed 2019-08-08
2019-03-3164.70%
10-Q · filed 2020-05-07
64.68%
10-Q · filed 2019-05-13
2018-12-3160.12%
10-K · filed 2020-03-12
2018-09-3056.70%
10-Q · filed 2019-11-12
56.64%
10-Q · filed 2018-11-13
60.12%
10-Q · filed 2019-11-12
2018-06-3060.12%
10-Q · filed 2019-08-08
2018-03-3160.12%
10-Q · filed 2019-05-13
2017-12-3159.40%
10-K · filed 2019-03-12
2017-09-3054.38%
10-Q · filed 2018-11-13
2017-06-3053.53%
10-Q · filed 2018-08-13
2017-03-3159.40%
10-Q · filed 2018-05-14